BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32039826)

  • 1. Investigation of key miRNAs and potential mechanisms in non-small cell lung cancer development from chronic obstructive pulmonary disease.
    Denkçeken T; Pala E
    Gen Physiol Biophys; 2020 Jan; 39(1):69-77. PubMed ID: 32039826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of Potential miRNA-mRNA Regulatory Network in COPD Plasma by Bioinformatics Analysis.
    Zhu M; Ye M; Wang J; Ye L; Jin M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2135-2145. PubMed ID: 32982206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
    Wang K; Chen M; Wu W
    World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of microRNA and gene expression profiles reveals a functional regulatory module associated with liver fibrosis.
    Chen W; Zhao W; Yang A; Xu A; Wang H; Cong M; Liu T; Wang P; You H
    Gene; 2017 Dec; 636():87-95. PubMed ID: 28919164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
    Liu M; Zhu K; Qian X; Li W
    Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease.
    Duan Y; Zhou M; Xiao J; Wu C; Zhou L; Zhou F; Du C; Song Y
    Int J Mol Med; 2016 Nov; 38(5):1450-1462. PubMed ID: 28025995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
    Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
    Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analyses of the pathogenesis and new biomarkers of chronic obstructive pulmonary disease.
    Zhang J; Liu J; Xu S; Yu X; Zhang Y; Li X; Zhang L; Yang J; Xing X
    Medicine (Baltimore); 2021 Nov; 100(46):e27737. PubMed ID: 34797299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA‑gene pairs in small‑cell lung cancer.
    Mao Y; Xue P; Li L; Xu P; Cai Y; Chu X; Jiang P; Zhu S
    Mol Med Rep; 2019 Sep; 20(3):2199-2208. PubMed ID: 31257520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
    Li T; Gao X; Han L; Yu J; Li H
    World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
    Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
    Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of miRNA-mRNA crosstalk in pancreatic cancer by integrating transcriptome analysis.
    Yang J; Zeng Y
    Eur Rev Med Pharmacol Sci; 2015; 19(5):825-34. PubMed ID: 25807437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple microarray analyses identify key genes associated with the development of Non-Small Cell Lung Cancer from Chronic Obstructive Pulmonary Disease.
    Zhang L; Chen J; Yang H; Pan C; Li H; Luo Y; Cheng T
    J Cancer; 2021; 12(4):996-1010. PubMed ID: 33442399
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
    Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
    Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of non-small-cell lung cancer microarray datasets identifies several prognostic biomarkers.
    Qin X; Chen R; Xiong R; Tan Z; Gao S; Lin C; Huo T
    Future Oncol; 2019 Sep; 15(27):3135-3148. PubMed ID: 31426680
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening key miRNAs for human hepatocellular carcinoma based on miRNA-mRNA functional synergistic network.
    Zhang CJ; Du HJ
    Neoplasma; 2017; 64(6):816-823. PubMed ID: 28895405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both Peripheral Blood and Urinary miR-195-5p, miR-192-3p, miR-328-5p and Their Target Genes PPM1A, RAB1A and BRSK1 May Be Potential Biomarkers for Membranous Nephropathy.
    Zhou G; Zhang X; Wang W; Zhang W; Wang H; Xin G
    Med Sci Monit; 2019 Mar; 25():1903-1916. PubMed ID: 30865617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.